DBV Technologies reported $-18020000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
DBV Technologies DBVT:US USD -18020000 5.8M
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Alnylam Pharmaceuticals ALNY:US USD -258040000 66.35M
Amarin AMRN:US USD 1.43M 39.05M
Biocryst Pharmaceuticals BCRX:US USD -17445000 17.28M
Biomarin Pharmaceutical BMRN:US USD 2.38M 36.77M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
Galectin Therapeutics GALT:US USD -8122000 1.54M
Halozyme Therapeutics HALO:US USD 83.69M 49.63M
Insmed INSM:US USD -122459000 21.52M
Intercept Pharmaceuticals ICPT:US USD -10144000 3.22M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
Neurocrine Biosciences NBIX:US USD 87.8M 33.1M
Ptc Therapeutics PTCT:US USD -68187000 24.17M
Sarepta Therapeutics SRPT:US USD -131355000 79.78M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
United Therapeutics UTHR:US USD 314.3M 112.5M
YTE INCY:US USD 118.25M 142.04M